JP2022521818A5 - - Google Patents

Info

Publication number
JP2022521818A5
JP2022521818A5 JP2021557342A JP2021557342A JP2022521818A5 JP 2022521818 A5 JP2022521818 A5 JP 2022521818A5 JP 2021557342 A JP2021557342 A JP 2021557342A JP 2021557342 A JP2021557342 A JP 2021557342A JP 2022521818 A5 JP2022521818 A5 JP 2022521818A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
optionally substituted
compound
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021557342A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521818A (ja
JP7609798B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/024654 external-priority patent/WO2020198323A1/en
Publication of JP2022521818A publication Critical patent/JP2022521818A/ja
Publication of JP2022521818A5 publication Critical patent/JP2022521818A5/ja
Application granted granted Critical
Publication of JP7609798B2 publication Critical patent/JP7609798B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021557342A 2019-03-25 2020-03-25 Prmt5インヒビター及びその使用 Active JP7609798B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962823374P 2019-03-25 2019-03-25
US62/823,374 2019-03-25
US201962874773P 2019-07-16 2019-07-16
US62/874,773 2019-07-16
PCT/US2020/024654 WO2020198323A1 (en) 2019-03-25 2020-03-25 Prmt5 inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2022521818A JP2022521818A (ja) 2022-04-12
JP2022521818A5 true JP2022521818A5 (cg-RX-API-DMAC7.html) 2023-04-03
JP7609798B2 JP7609798B2 (ja) 2025-01-07

Family

ID=72609147

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021557342A Active JP7609798B2 (ja) 2019-03-25 2020-03-25 Prmt5インヒビター及びその使用

Country Status (12)

Country Link
US (1) US12583859B2 (cg-RX-API-DMAC7.html)
EP (1) EP3947387B1 (cg-RX-API-DMAC7.html)
JP (1) JP7609798B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220023330A (cg-RX-API-DMAC7.html)
CN (1) CN114127072B (cg-RX-API-DMAC7.html)
AU (1) AU2020245480A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021019125A2 (cg-RX-API-DMAC7.html)
CA (1) CA3134779A1 (cg-RX-API-DMAC7.html)
IL (2) IL318073A (cg-RX-API-DMAC7.html)
MX (1) MX2021011524A (cg-RX-API-DMAC7.html)
SG (1) SG11202110272SA (cg-RX-API-DMAC7.html)
WO (1) WO2020198323A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11077101B1 (en) 2018-07-18 2021-08-03 Tango Therapeutics, Inc. Compounds and methods of use
EP3947387B1 (en) 2019-03-25 2024-10-23 California Institute Of Technology Prmt5 inhibitors and uses thereof
US12403137B2 (en) 2019-10-28 2025-09-02 Tango Therapeutics, Inc. Compounds and methods of use
CN116568677B (zh) 2020-07-31 2026-07-28 探戈医药股份有限公司 可用于治疗mtap缺乏和/或mta累积癌症的哌啶-1-基-n-吡啶-3-基-2-氧代乙酰胺衍生物
CN117157297B (zh) * 2021-07-20 2026-06-16 上海齐鲁制药研究中心有限公司 Prmt5抑制剂
WO2023127857A1 (ja) * 2021-12-27 2023-07-06 株式会社理研ジェネシス 新規人工核酸、その製造方法及び用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143749A (en) 1995-06-07 2000-11-07 Abbott Laboratories Heterocyclic substituted cyclopentane compounds
GB0004297D0 (en) 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6875751B2 (en) 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
CA2903394C (en) * 2013-03-14 2021-08-31 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
EA031895B1 (ru) 2015-02-24 2019-03-29 Пфайзер Инк. Замещенные нуклеозидные производные, полезные в качестве агентов против рака
TWI730980B (zh) * 2015-08-26 2021-06-21 比利時商健生藥品公司 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物
CN108884108B (zh) * 2016-03-10 2021-08-31 詹森药业有限公司 用于用作prmt5抑制剂的取代核苷类似物
CA2969295A1 (en) 2016-06-06 2017-12-06 Pfizer Inc. Substituted carbonucleoside derivatives, and use thereof as a prmt5 inhibitor
WO2018065365A1 (en) * 2016-10-03 2018-04-12 Janssen Pharmaceutica Nv Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors
WO2018160824A1 (en) 2017-03-01 2018-09-07 Prelude Therapeutics, Incorporated Selective inhibitors of protein arginine methyltransferase 5 (prmt5)
MA49840A (fr) * 2017-08-09 2020-06-17 Prelude Therapeutics Inc Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5)
MX2020005944A (es) * 2017-12-08 2020-08-24 Janssen Pharmaceutica Nv Analogos espirobiciclicos novedosos.
EP3947387B1 (en) 2019-03-25 2024-10-23 California Institute Of Technology Prmt5 inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2022507514A5 (cg-RX-API-DMAC7.html)
RU2441005C2 (ru) Новые пиразолопиримидины как ингибиторы циклинзависимых киназ
JP2021512059A5 (cg-RX-API-DMAC7.html)
JP2008505167A5 (cg-RX-API-DMAC7.html)
RU2008122048A (ru) Аминопиримины в качестве ингибиторов киназ
RU2003118446A (ru) Пролекарства цианогуанидина
JP2021510376A5 (cg-RX-API-DMAC7.html)
JP2021512166A5 (cg-RX-API-DMAC7.html)
JP2018138577A5 (cg-RX-API-DMAC7.html)
JP2023509366A5 (cg-RX-API-DMAC7.html)
JP2016513660A5 (cg-RX-API-DMAC7.html)
JP2009543771A5 (cg-RX-API-DMAC7.html)
JP2013522292A5 (cg-RX-API-DMAC7.html)
JP2021516242A5 (cg-RX-API-DMAC7.html)
JP2021533135A5 (cg-RX-API-DMAC7.html)
JP2014527082A5 (cg-RX-API-DMAC7.html)
RU2007130076A (ru) Антагонисты cxcr4 для лечения внутренних болезней
JP2023526283A5 (cg-RX-API-DMAC7.html)
RU2015118647A (ru) Аминопиримидиновые соединения в качестве ингибиторов содержащих т790м мутантных egfr
EA201391324A1 (ru) Бис(фторалкил)-1,4-бензодиазепиноновые соединения
JP2004520282A5 (cg-RX-API-DMAC7.html)
JP2025502377A5 (cg-RX-API-DMAC7.html)
JP2023508328A5 (cg-RX-API-DMAC7.html)
CA2447021A1 (en) Pyridyl cyanoguanidine compounds
JP2008506761A5 (cg-RX-API-DMAC7.html)